GMED — Globus Medical Inc. stock price and chart

Share this page

GMED

$75.60+1.60%

as of close, Oct 2, 2026

☾ AH $75.60 +1.60%

Globus Medical Inc.Stock · Health CareRussell 1000 0.01%US Stock Market 0.01%Russell 3000 0.01%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

30.040.050.060.070.080.090.0020.0M40.0M$75.60

2026-10-02

Price$75.60

MA20$80.65

MA50$78.64

Vol8.9M

What would $1,000 invested in GMED be worth today? →

GMED returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $75.60
Change YTD: -13.41%
Next earnings: Nov 5, 2026
Market cap: 10.2B2016-12 2.4B2026-10 10.2B+326.9% over the window
Enterprise value: 9.7B
Shares outstanding: 134.3M2016-06 95.7M2026-06 134.3M+40.4% over the window
52W low: $56.50
52W high: $101.40
From 52W high: -25.44%
From 52W low: +33.81%
52W range: 43%
Beta: 0.96

Volume

Rel volume: 0.93×
30D volume: 1.4M
30D $ vol: 108.4M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1M0 insider-days of buying (no priced lot) and 1 of selling ($2.2M) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$2.2M
Insider net 3M0 insider-days of buying (no priced lot) and 2 of selling ($4.4M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$4.4M
Insider net 1Y0 insider-days of buying (no priced lot) and 7 of selling ($9.8M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$9.8M

Form 4 transactions by trade date, as filed; latest on file 2026-09-15.

Fundamentals

Sales (ttm): 3.1B2016-06 556.3M2026-06 3.1B+465.3% over the window
Sales/share: $23.422016-06 $5.822026-06 $23.42+302.7% over the window
EPS (ttm): $3.912016-06 $1.232026-06 $3.91+218.0% over the window
FCF (ttm): 755.6M2016-06 109.2M2026-06 755.6M+591.8% over the window
FCF/share: $5.632016-06 $1.142026-06 $5.63+392.8% over the window
Book value/share: $35.522016-06 $8.152026-06 $35.52+335.8% over the window
Net margin: 17.03%2016-06 21.2%2026-06 17.0%-19.7% over the window
ROE: 11.23%2016-06 15.1%2026-06 11.2%-25.8% over the window
ROA: 9.76%2016-06 13.6%2026-06 9.8%-28.1% over the window
Current ratio: 4.622016-06 7.622026-06 4.62-39.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +19.76%2025-06-30 → 2026-06-302.6B → 3.1B (+19.7% total)+42.05%2023-06-30 → 2026-06-301.1B → 3.1B (+186.7% total)+28.92%2021-09-30 → 2026-06-30941.5M → 3.1B (+234.0% total)+18.92%2016-06-30 → 2026-06-30556.3M → 3.1B (+465.3% total)
Net income: +50.17%2025-06-30 → 2026-06-30356.6M → 535.4M (+50.1% total)+37.85%2023-06-30 → 2026-06-30204.3M → 535.4M (+162.0% total)+24.80%2021-09-30 → 2026-06-30187M → 535.4M (+186.3% total)+16.34%2016-06-30 → 2026-06-30117.9M → 535.4M (+354.1% total)
FCF: +43.29%2025-06-30 → 2026-06-30527.4M → 755.6M (+43.3% total)+84.09%2023-06-30 → 2026-06-30121.1M → 755.6M (+524.2% total)+24.97%2021-09-30 → 2026-06-30262.2M → 755.6M (+188.2% total)+21.34%2016-06-30 → 2026-06-30109.2M → 755.6M (+591.8% total)
Shares: -0.59%2025-06-30 → 2026-06-30135.1M → 134.3M (-0.6% total)+10.15%2023-06-30 → 2026-06-30100.5M → 134.3M (+33.6% total)+5.88%2021-06-30 → 2026-06-30100.9M → 134.3M (+33.1% total)+3.45%2016-06-30 → 2026-06-3095.7M → 134.3M (+40.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +51.96%2025-06-30 → 2026-06-30$2.57 → $3.91 (+51.9% total)+24.94%2023-06-30 → 2026-06-30$2.01 → $3.91 (+95.1% total)+17.50%2021-09-30 → 2026-06-30$1.82 → $3.91 (+115.0% total)+12.27%2016-06-30 → 2026-06-30$1.23 → $3.91 (+218.0% total)
Sales/share: +20.47%2025-06-30 → 2026-06-30$19.45 → $23.42 (+20.4% total)+28.96%2023-06-30 → 2026-06-30$10.92 → $23.42 (+114.5% total)+21.54%2021-09-30 → 2026-06-30$9.28 → $23.42 (+152.4% total)+14.95%2016-06-30 → 2026-06-30$5.82 → $23.42 (+302.7% total)
FCF/share: +44.14%2025-06-30 → 2026-06-30$3.91 → $5.63 (+44.1% total)+67.13%2023-06-30 → 2026-06-30$1.20 → $5.63 (+367.0% total)+17.82%2021-09-30 → 2026-06-30$2.58 → $5.63 (+117.8% total)+17.30%2016-06-30 → 2026-06-30$1.14 → $5.63 (+392.8% total)
Book value/share: +11.68%2025-06-30 → 2026-06-30$31.81 → $35.52 (+11.7% total)+21.58%2023-06-30 → 2026-06-30$19.76 → $35.52 (+79.7% total)+16.93%2021-06-30 → 2026-06-30$16.25 → $35.52 (+118.6% total)+15.86%2016-06-30 → 2026-06-30$8.15 → $35.52 (+335.8% total)
Price: +30.23%2025-10-02 → 2026-10-02$58.06 → $75.60 (+30.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.09%2023-10-02 → 2026-10-02$49.59 → $75.60 (+52.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.88%2021-10-01 → 2026-10-02$79.00 → $75.60 (-4.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+12.84%2016-09-30 → 2026-10-02$22.57 → $75.60 (+235.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +30.23%2025-10-02 → 2026-10-02$58.06 → $75.60 (+30.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.09%2023-10-02 → 2026-10-02$49.59 → $75.60 (+52.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.88%2021-10-01 → 2026-10-02$79.00 → $75.60 (-4.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.84%2016-09-30 → 2026-10-02$22.57 → $75.60 (+235.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 19.3×2016-12 20.212026-10 18.96-6.2% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 15.9×2016-12 13.632026-10 15.87+16.4% over the window
Fwd P/E: 13.9×
P/S (ttm)Market cap ÷ TTM revenue.: 3.2×2016-12 4.282026-10 3.23-24.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.1×2016-12 2.932026-10 2.13-27.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 13.4×2016-12 18.762026-10 13.43-28.4% over the window
EV/EBITDA (fy): 10.5×
EV/Sales (ttm): 3.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 7.44%2016-09 5.3%2026-06 7.1%+33.6% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 134.3M ÷ 135.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 0.59%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (0.59%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 0.59%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($221.1M) ÷ today's market cap ($10.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.18%2016-09 0.2%2026-06 2.1%+1048.7% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $221.1M + TTM dividends $0) ÷ today's market cap ($10.2B). Same caveat as the cash buyback yield.: 2.18%2016-09 0.2%2026-06 2.1%+1048.7% over the window

Vs own 10Y history

P/E: 4th
P/OI: 4th
P/S: 5th
P/B: 12th
P/FCF: 1st

Bar = where today’s multiple sits in GMED’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-02

+1.60%

+1.45%

-6.27%

-5.64%

YTD

-13.41%

+30.21%

-4.30%

Recent filings

Sep 15Insider sale · TOBIN JAMES R (Director) sold 30,000 Class A shares for $2.2M at $74.58
Aug 18Insider sale · ZARRILLI STEPHEN T (Director) sold 25,000 Class A shares for $2.2M at $87.04
Aug 6Earnings · Earnings release — EPS $1.34 vs $1.12 est. (+19.6%); revenue $789.6M (+6% y/y) 1.6%
Aug 6Report · Quarterly report, Q2 2026 — revenue $789.6M (+6% y/y), net income $151.6M, EPS $1.10
Jun 5Insider sale · Davidar David D (Director) sold 25,000 Class A shares for $2.0M at $80.76

All filings and insider trades →

Financial statements

Open full GMED financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-13.21%	-0.04%
NVO	Novo Nordisk A/S	-20.21%	-0.21%
SNY	Sanofi ADS	-10.23%	-1.84%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-6.76%	-0.32%
NTRA	Natera Inc.	+26.20%	+0.46%
ARGX	argenx SE American Depositary Shares	-12.90%	-1.79%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	-3.09%	+0.00%
TEVA	Teva Pharmaceutical Industries Limited American Depositary Shares	+5.44%	+0.56%

GMED — Globus Medical Inc. price, chart and key statistics